Empowering Africa's Drug Discovery
Magami Open Sciences (Magami OS) Initiative is a non-profit, open-science AI-for-good research organisation that accelerates drug discovery research for Africans using AI.
Africa bears the largest burden of infectious and Neglected Tropical Diseases (NTDs), which simultaneously now receives the least funding. At Magami OS, we aim to bridge the gap collaborate with researchers, provide essential training, and develop open-source AI tools to enhance drug discovery research across the continent.
Our Approach
AI Collaboration for Drug Discovery
We partner with African researchers at any stage of drug discovery to leverage AI technology, providing necessary expertise and resources for successful outcomes.
Capacity Development Training
We offer comprehensive training programs for biomedical researchers, empowering them with AI skills to enhance their research capabilities.
Open Source Software Development
We create and distribute open source software tools tailored for drug discovery research, ensuring accessibility and innovation for all researchers in Africa.
Gallery
Empowering Africa's researchers for a healthier tomorrow.
Join us in transforming drug discovery!
Connect with us to empower Africa's drug discovery innovations through AI collaboration and training.
Frequently Asked Questions
How does your organization measure the impact of its initiatives?
We assess our impact through various metrics, including the number of researchers trained, successful collaborations established, and advancements in drug discovery that result from the use of our resources and training.
What types of training programs do you offer?
We offer comprehensive training programs focused on AI technologies tailored for our partner researchers, which are then extended to other biomedical researchers across Africa to ensure broad access to knowledge and tools.
Who can benefit from the services offered by Magami Open Science Initiative?
Our services are designed for African researchers at any stage of drug discovery who wish to incorporate AI into their work, as well as biomedical researchers seeking to enhance their capabilities through training and software resources.